A medial collateral ligament (MCL) tear affects the inside of the knee. The tough MCL ligament fibers that connect the end of the femur (thigh bone) and the top of the tibia (shin bone) can tear, ...
Moussa Diarra, Málaga CF's centre-back currently on loan to Marbella FC for the 24/25 season, underwent surgery this Thursday ...
What treatment- and patient-specific factors do you consider when determining induction therapy for a treatment-naive patient with MCL (eg, aggressive vs less aggressive)?
HEMASHIELD PLATINUM Woven Double Velour Grafts are collagen-impregnated and come in straight, one-branch, or multi-branch graft configurations for aortic repair. Trusted for more than 20 years ...
The MAQUET line of FUSION grafts Graft merges ePTFE with PET, creating a completely new concept for peripheral vascular procedures. It delivers the easy handling of ePTFE with the reduced suture ...
Steroid therapy is the first-line treatment for graft-versus-host disease (GVHD). If GVHD does not respond to initial therapies, doctors may consider chemotherapy, monoclonal antibodies ...
...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this ...
In a 50-page decision promulgated on Feb. 6, the anti-graft court’s Sixth Division found Sultan Usman Sarangani guilty of 16 counts of violation of Section 3(e) of Republic Act 3019 or the Anti ...
The case is presented of a woman with a gradual onset of knee pain due to calcific tendonitis of the medial collateral ligament (MCL). The diagnosis was made based on clinical findings, plain ...
Values are mean ± SD, or N(%). ICU: intensive care unit, PTA: percutaneous transluminal angioplasty. In the AL group, 41 patients (61.4%) received additional treatment. Seven patients (10.0%) received ...
It is still dwarfed by J&J and AbbVie's blockbuster though, which made around $8.4 billion in 2020 from half a dozen indications, including CLL and other blood cancers as well as chronic graft ...
A team of researchers at Cornell University has developed a new biodegradable vascular graft that could transform the treatment of cardiovascular disease, the leading cause of death worldwide.